Abstract
Presently, there are no effective treatments for conditions characterized by protein misfolding, such as Alzheimer's, Parkinson's, and other diseases involving CNS. Since misfolding occurs at the earliest stage of the disease, it is likely to be involved in subsequent pathological developments. It has been found that NPT002 (bacteriophage M13) directly dissociates aggregates of misfolded proteins that form amyloid, including amyloid-β, tau and α-synuclein. For CNS applications, NPT002 requires delivery to the brain parenchyma, the target tissue. NPT002 is an elongated ~950 nm particle that cannot penetrate into the brain from the blood. Furthermore, phage particles, due to their size, cannot be effectively transported in vivo by diffusion. Considering the physiology of the leptomeningeal space, intrathecal administration appears to be a promising convection-driven avenue for NPT002 delivery. In this paper, we use positron emission tomography to investigate the transport of NPT002 in Macaca fascicularis. The data suggest that approximately 50 % of the administered dose can reach the cerebral leptomeningeal space after a single lumbar intrathecal injection. A biologically significant fraction of the phage then enters the brain, r...Continue Reading
References
Feb 4, 1985·Brain Research·M L RennelsP A Grady
Jan 1, 1972·Acta Radiologica: Diagnosis·G Du BoulayP Verity
Apr 30, 1974·Acta Neuropathologica·H J WagnerJ Brandl
Apr 1, 1966·The British Journal of Radiology·G H Du Boulay
Nov 1, 1969·Gut·R M HardenD Chisholm
Jun 3, 1982·Brain Research·J E LevineD P Becker
Apr 1, 1997·IEEE Transactions on Medical Imaging·M DefriseD F Newport
Apr 3, 2003·Journal of Bacteriology·Fredrik KarlssonAnn-Christin Malmborg-Hager
Feb 1, 1964·Acta Radiologica: Therapy, Physics, Biology·S ULLBERG, B EWALDSSON
Jan 1, 1965·The Journal of Clinical Investigation·M T HAYS, D H SOLOMON
Dec 1, 2005·The Journal of Biological Chemistry·Jessica E FriedmanSteven E Rokita
Mar 3, 2011·Molecular Pharmaceutics·Vasily V BelovMikhail I Papisov
Jan 27, 2012·PloS One·Pericles CaliasMichael W Heartlein
Jun 1, 2012·Drug Delivery and Translational Research·Mikhail I PapisovC Gillooly
Citations
Jan 16, 2013·Molecular Pharmaceutics·Mikhail I PapisovKimberley S Gannon
Jul 13, 2018·JCI Insight·Geir RingstadPer K Eide
Jun 14, 2019·Frontiers in Neuroscience·Beata DurcanovaMikhail Papisov
Mar 7, 2020·Advanced Drug Delivery Reviews·M J FowlerR W Sirianni
May 4, 2021·Frontiers in Neuroscience·Vasily BelovMikhail Papisov